庄严
发表于 2025-3-23 12:33:26
http://reply.papertrans.cn/16/1504/150349/150349_11.png
Criteria
发表于 2025-3-23 15:09:04
http://reply.papertrans.cn/16/1504/150349/150349_12.png
exclusice
发表于 2025-3-23 21:54:56
http://reply.papertrans.cn/16/1504/150349/150349_13.png
triptans
发表于 2025-3-23 23:40:02
Summary and Future Work,In conclusion, with the goal to improve PCa early detection for better disease risk stratification in the clinic, this book has advanced both the fields of clinical PCa screening methodologies and accurate non-invasive identification of aggressive PCa subtypes from urine samples.
Permanent
发表于 2025-3-24 05:26:03
https://doi.org/10.1007/978-3-030-31000-4Prostate Cancer Detection; Precision Medicine; Urinary Nanodiagnostics; Clinical Translation; Biosensor
DEFER
发表于 2025-3-24 07:46:52
978-3-030-31002-8Springer Nature Switzerland AG 2019
ABHOR
发表于 2025-3-24 13:37:05
Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics978-3-030-31000-4Series ISSN 2190-5053 Series E-ISSN 2190-5061
纠缠
发表于 2025-3-24 18:14:19
Phil Howlett,Julia Piantadosi,Charles PearceG detection in patient urinary samples by coupling the isothermal reverse transcription-recombinase polymerization amplification (RT-RPA) to amplify TMPRSS2-ERG transcripts and directly detect the amplicons using surface-enhanced Raman scattering (SERS).
保留
发表于 2025-3-24 21:22:18
http://reply.papertrans.cn/16/1504/150349/150349_19.png
Parabola
发表于 2025-3-25 02:47:08
2190-5053 roduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development..978-3-030-31002-8978-3-030-31000-4Series ISSN 2190-5053 Series E-ISSN 2190-5061